coronavirus
histor
associ
low
impact
human
diseas
common
cold
sudden
emerg
sever
acut
respiratori
syndrom
sar
coronaviru
cov
made
us
awar
deadli
version
coronavirus
caus
larg
outbreak
associ
high
mortal
global
panic
sarscov
caus
outbreak
deem
pandem
intern
threat
world
health
organ
total
peopl
infect
die
extens
epidemiolog
studi
wildlif
surveil
reveal
sarscov
origin
bat
somehow
spread
civet
cat
viru
specul
later
jump
civet
cat
human
outbreak
establish
import
wildlif
ie
bat
emerg
highli
pathogen
coronavirus
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
septemb
kingdom
saudi
arabia
merscov
caus
lower
respiratori
tract
infect
human
mortal
sinc
emerg
laboratoryconfirm
case
identifi
human
death
twentyseven
countri
report
case
mer
mani
associ
travel
merscov
list
blueprint
prioriti
diseas
need
immedi
research
current
support
treatment
exist
merscov
merscov
like
mani
virus
evolv
protein
effect
counteract
human
antivir
respons
sudden
appear
mer
high
infect
rate
viru
need
high
contain
level
lab
research
hinder
progress
design
vaccin
therapeut
viru
develop
vaccin
candid
complic
abil
coronavirus
rapidli
mutat
recombin
sever
quasispeci
viru
detect
camel
reservoir
viru
extrem
difficult
develop
therapeut
strategi
pathogen
exist
sever
differ
variant
evolut
merscov
intrigu
specul
merscov
origin
spill
bat
camel
sever
merslik
cov
detect
bat
current
model
propos
camel
reservoir
viru
often
sourc
human
infect
humantohuman
transmiss
merscov
also
document
spite
advanc
understand
viru
evolv
signific
lack
knowledg
viru
transmiss
dynam
ecolog
environment
factor
drive
emerg
evolut
merscov
sever
novel
approach
current
develop
combat
merscov
includ
small
molecul
inhibitor
monoclon
antibodi
vaccin
minireview
discuss
pathogenesi
merscov
role
variou
viral
protein
subvert
antivir
respons
human
also
discuss
current
approach
develop
test
control
merscov
replic
associ
diseas
final
bring
forward
addit
strategi
identifi
therapeut
target
molecul
improv
outcom
merscov
infect
human
matur
cov
particl
spheric
shape
diamet
around
nm
viru
particl
protein
coat
call
capsid
protect
viru
genet
materi
cov
addit
envelop
lipid
surround
protein
capsid
layer
deriv
portion
host
cell
membran
phospholipid
protein
also
includ
viral
glycoprotein
cov
virion
contain
four
essenti
viral
membran
envelop
e
nucleocapsid
n
encod
within
end
viral
genom
protein
clubshap
locat
surfac
virion
give
cov
distinct
appear
solar
corona
henc
protein
critic
initi
attach
virion
host
cell
receptor
dipeptidyl
peptidas
recent
studi
demonstr
spike
protein
adapt
interact
differ
speci
bat
enabl
crossspeci
entri
replic
merscov
structur
cov
maintain
protein
e
protein
facilit
assembl
releas
viru
cov
helic
symmetr
nucleocapsid
structur
protein
associ
nucleocapsid
n
protein
help
packag
viru
genom
review
virus
use
host
cell
machineri
replic
fig
cov
larg
nonseg
positivesens
rna
genom
kb
use
rna
replicas
enzym
creat
copi
genom
cytoplasm
cov
complet
life
cycl
step
entri
express
replicas
protein
replic
transcript
genom
releas
assembl
progeni
virion
review
fig
cov
interact
protein
cognat
receptor
surfac
suscept
cell
specif
interact
determin
host
rang
tissu
tropism
cov
mani
cov
bind
peptidas
cognat
receptor
entri
choic
receptor
report
vari
across
differ
cov
exampl
sarscov
use
angiotensinconvert
enzym
merscov
bind
subsequ
protein
undergo
aciddepend
proteolyt
cleavag
result
fusion
viral
cellular
membran
releas
viral
genom
cytoplasm
review
coronaviru
genom
includ
cap
structur
poli
tail
allow
act
messeng
rna
mrna
positivesens
rna
templat
translat
replicas
polyprotein
replicas
gene
encod
two
larg
open
read
frame
orf
express
two
cotermin
polyprotein
polyprotein
cleav
individu
nonstructur
protein
nsp
encod
papainlik
proteas
plpro
cleav
boundari
serinetyp
proteas
also
known
main
proteas
mpro
encod
cleav
polyprotein
remain
nsp
nsp
facilit
viral
rna
synthesi
exampl
encod
rnadepend
rna
polymeras
rdrp
format
replicasetranscriptas
complex
rtc
contain
nsp
initi
viral
rna
synthesi
rtc
complex
local
modifi
intracellular
membran
deriv
rough
endoplasm
reticulum
er
initi
product
negativesens
rna
replic
transcript
fulllength
copi
cov
negativesens
rna
genom
serv
templat
synthes
fulllength
positivesens
rna
genom
eventu
get
packag
new
virion
cov
util
discontinu
transcript
gener
subset
subgenom
negativesens
rna
includ
encod
structur
protein
vari
length
end
genom
combin
leader
sequenc
make
subgenom
negativesens
rna
subgenom
negativesens
rna
transcrib
subgenom
positivesens
mrna
translat
viral
structur
protein
e
translat
subgenom
positivesens
mrna
structur
protein
insert
endoplasm
reticulumgolgi
intermedi
compart
ergic
viral
genom
encapsid
n
protein
bud
ergic
contain
structur
protein
assembl
newli
assembl
matur
virion
transport
cell
surfac
vesicl
releas
infect
cell
exocytosi
genom
organ
replic
associ
replicasetranscriptas
protein
murin
hepat
viru
mhv
extens
studi
identifi
coronavirus
use
similar
replic
strategi
review
patholog
chang
merscov
infect
patient
studi
help
singl
researchori
autopsi
patholog
fatal
case
primarili
includ
exud
diffus
alveolar
damag
hyalin
membran
pulmonari
edema
type
pneumocyt
hyperplasia
interstiti
pneumonia
predominantli
lymphocyt
multinucl
syncyti
cell
sever
studi
character
merscov
cell
line
anim
model
like
virus
merscov
evolv
strategi
evad
innat
antivir
respons
abil
viru
suppress
antivir
respons
promot
exagger
inflammatori
respons
contribut
pathogenesi
describ
merscov
made
sever
structur
nonstructur
accessori
protein
merscov
accessori
protein
dispens
viru
replic
tissu
cultur
play
import
role
modul
host
antivir
defens
respons
human
mammalian
cell
evolv
evolutionarili
conserv
molecul
pattern
recognit
receptor
prr
detect
conserv
structur
virus
call
pathogenassoci
molecular
pattern
coronaviru
infect
enter
cell
releas
rna
genom
rapidli
initi
process
translat
rna
replic
transcript
process
produc
long
strand
singl
doublestrand
rna
dsrna
cell
detect
exogen
singl
dsrna
prr
tolllik
receptor
tlr
retino
acidinduc
gene
rigi
melanoma
protein
prr
initi
seri
signal
event
cell
stimul
express
antivir
protein
interferon
ifn
turn
express
interferonstimul
gene
isg
infect
cell
autocrin
effect
neighbor
uninfect
cell
paracrin
effect
review
thu
battl
host
infect
individu
pathogen
merscov
begin
molecular
level
merscov
evolv
sever
accessori
protein
inhibit
innat
antivir
respons
modul
signal
pathway
sever
stage
fig
merscov
protein
orf
inhibit
pactinduc
activ
rigi
directli
bind
dsrna
fig
pact
cellular
dsrna
bind
protein
activ
rigi
initi
downstream
antivir
respons
thu
orf
inhibit
antivir
respons
first
step
viral
nucleic
acid
sens
interferon
regulatori
factor
central
mediat
antivir
signal
human
cell
thu
activ
also
target
sever
viral
protein
includ
protein
merscov
human
cell
tlr
rigi
sens
viral
nucleic
acid
cell
activ
kinas
tankbind
kinas
inhibitor
nuclear
factor
kappab
kinas
subunit
epsilon
phosphoryl
phosphoryl
form
dimer
cytoplasm
local
nucleu
cell
initi
express
ifn
merscov
orf
protein
inhibit
kinasemedi
phosphoryl
fig
ectop
express
protein
inhibit
nuclear
local
human
cell
downstream
antivir
signal
respons
viru
infect
synthet
dsrna
polyi
c
stimul
although
cellular
interact
partner
merscov
viral
protein
identifi
protein
shown
inactiv
phosphoryl
disrupt
associ
merscov
orf
also
inhibit
nuclear
factor
kappalightchainenhanc
activ
b
cell
antivir
respons
abrog
nuclear
import
signal
transduc
activ
transcript
fig
addit
accessori
protein
nsp
gener
polyprotein
also
play
role
modul
host
process
merscov
select
target
mrna
gener
nucleu
transport
cytoplasm
cellular
mrna
translat
inhibit
mrna
degrad
spare
mrna
introduc
directli
cytoplasm
viruslik
mrna
origin
cytoplasm
thu
inhibit
cellular
process
promot
viral
replic
limit
studi
merscov
larg
due
contain
requir
modul
adapt
immun
respons
merscov
extens
studi
cytokin
respons
infect
dendrit
cell
macrophag
white
blood
cell
fulli
explor
one
studi
antibodymedi
respons
seroconvers
observ
individu
develop
asymptomat
infect
merscov
patient
seroconvert
later
time
point
develop
pneumonia
without
respiratori
failur
although
rate
seroconvers
increas
diseas
sever
deceas
merscov
infect
patient
develop
pneumonia
seroconvert
anoth
studi
choi
et
al
demonstr
absenc
neutral
antibodi
one
year
success
treatment
merscov
infect
patient
develop
mild
pneumonia
observ
consist
previou
studi
diseas
sever
correl
seroconvers
inabl
produc
longterm
neutral
antibodi
would
put
individu
risk
reinfect
merscov
futur
possibl
need
monitor
studi
observ
warrant
investig
abil
merscov
modul
humor
respons
patient
role
cell
merscov
infect
recent
report
zhao
et
al
analyz
antibodi
cell
respons
peripher
blood
mononuclear
cell
pbmc
sera
twentyon
mer
survivor
author
identifi
patient
higher
antibodi
cell
respons
longer
intens
care
unit
stay
demonstr
prolong
viru
shed
studi
mer
survivor
undetect
merscovspecif
antibodi
respons
mount
cell
respons
observ
add
detail
previou
studi
neutral
antibodi
level
detect
mer
survivor
diseas
sever
correl
seroconvers
observ
rais
import
question
merscov
infect
augment
presenc
antibodi
merscov
infect
propag
macrophag
merscov
endoribonucleas
specul
suppress
activ
dsrna
sensor
infect
cell
macrophag
although
mechan
action
known
mutant
merscov
display
signific
dispers
dsrna
associ
replic
complex
rel
wildtyp
viru
sinc
macrophag
display
fc
receptor
bind
fc
portion
antibodi
interest
identifi
antibodi
bound
merscov
enhanc
viru
uptak
macrophag
subsequ
viru
replic
addit
replic
potenti
merscov
fc
immun
cell
need
explor
well
current
approv
treatment
vaccin
merscov
differ
approach
test
develop
inhibit
viru
replic
promis
preliminari
data
approach
extens
review
recent
review
mention
broad
strategi
current
discov
orient
reader
possibl
futur
treatment
prevent
option
commonli
studi
strategi
inhibit
viru
entri
human
cell
fig
previous
mention
merscov
bind
human
receptor
via
receptorbind
domain
rbd
spike
protein
monoclon
antibodi
rbd
receptorbind
motif
within
rbd
develop
inhibit
interact
review
small
molecul
capabl
disrupt
interact
merscov
spike
protein
also
develop
test
review
merscov
entri
accomplish
fusion
viru
cellular
membran
mediat
region
viru
spike
protein
inhibitori
peptid
target
region
spike
protein
prevent
fusion
thu
entri
viru
also
develop
current
studi
focus
disrupt
interact
merscov
spike
protein
cellular
receptor
recent
discoveri
attach
factor
membraneassoci
glucoseregul
protein
augment
merscov
entri
complic
approach
need
identifi
target
addit
interact
partner
may
facilit
merscov
bind
entri
altern
interest
approach
led
xia
et
al
identifi
peptid
inhibit
merscov
fusion
studi
bat
coronaviru
author
identifi
inhibitori
peptid
domain
spike
protein
peptid
abl
significantli
inhibit
merscovmedi
cellcel
fusion
viral
infect
human
cell
also
shown
merscov
strain
inhibit
antivir
respons
insectivor
bat
cell
unlik
human
cell
wildtyp
viru
effici
inhibit
respons
futur
studi
explor
antivir
adapt
bat
camelid
reservoir
speci
may
enabl
us
identifi
better
therapeut
target
spillov
mammal
human
attempt
ongo
develop
vaccin
therapeut
human
consider
progress
made
develop
vaccin
camel
sinc
merscov
transmiss
primarili
document
camel
human
interest
develop
vaccin
inhibit
viru
replic
camel
would
limit
cycl
transmiss
recent
studi
provid
promis
data
adjuv
merscov
spike
protein
subunit
vaccin
confer
complet
protect
merscov
diseas
alpaca
result
reduc
delay
viral
shed
upper
airway
dromedari
camel
relev
advanc
develop
merscov
vaccin
review
merscov
emerg
pathogen
necessit
immedi
research
develop
therapeut
vaccin
candid
unlik
sarscov
merscov
emerg
spread
caus
global
pandem
yet
risk
emerg
effici
humantohuman
transmiss
strain
unless
develop
intervent
strategi
current
circul
strain
merscov
lack
resourc
need
high
contain
lab
hinder
attempt
studi
viru
need
isol
strain
merscov
determin
variat
circul
strain
associ
pathogenesi
correl
protect
surviv
patient
well
defin
earli
intervent
seem
offer
protect
howev
easi
confus
earli
symptom
mer
common
cold
need
establish
public
commun
strategi
priorit
patient
known
contact
camel
observ
studi
combin
treatment
interferonbeta
ribavirin
identifi
effect
earlystag
patient
patient
diagnos
late
ongo
clinic
trial
studi
efficaci
interferon
antivir
combin
treatment
merscov
infect
patient
studi
shed
light
possibl
way
treat
mer
patient
meantim
ongo
research
identifi
sever
novel
strategi
inhibit
merscov
entri
replic
cell
thu
futur
might
possibl
use
experiment
treatment
option
combin
alon
prevent
onset
sever
diseas
patient
like
expos
merscov
howev
time
treatment
crucial
essenti
identifi
patient
earli
stage
infect
emphas
need
effect
differenti
diagnost
appropri
train
healthcar
profession
vaccin
coronavirus
challeng
develop
due
abil
coronavirus
recombin
possibl
exacerb
diseas
symptom
post
immun
challeng
howev
subunit
vaccin
use
spike
protein
gener
promis
result
camelid
may
one
day
suitabl
humanus
although
near
futur
